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Abstract
Introduction: The objective of this study was to investigate the clinical
features of depression in Asian patients.
Methods: It was a cross-sectional, observational study of depression in
China, Korea, Malaysia, Singapore, Taiwan, and Thailand. Participants
were drug-free outpatients with depressed mood and/or anhedonia.
Symptoms and clinical features were assessed using the Montgomery–
Asberg Depression Rating Scale, Symptoms Checklist 90-Revised (SCL-90-
R), and the Fatigue Severity Scale. Other measures included the Medical
Outcome Survey 36-Item Short-Form Health Survey (SF-36), the
Sheehan Disability Scale, and the Multidimensional Scale of Perceived
Social Support (MSPSS).
Results: A total of 547 outpatients with major depressive disorder were
included in the analyses. Among the Montgomery–Asberg Depression
Rating Scale symptoms, “reported sadness” and “reduced sleep” had the
highest severity, with means (SDs) of 3.4 (1.2) and 3.4 (1.6), respectively.
Apart from the SCL-90-R depression and anxiety domains, the SCL-90-R
obsession–compulsion syndrome had the highest domain score, with a
mean (SD) of 1.9 (0.9). Among eight domains, the mean (SD) SF-36 pain
subscale score of 58.4 (27.7) was only second to that for the SF-36 physical
function. In comparison to other disability domains, the Sheehan Disabil-
ity Scale work/school had the highest subscale score, with a mean (SD) of
6.5 (2.9). The mean (SD) MSPSS “family” subscale score of 4.7 (1.7) was
higher than the MSPSS “friends” and “significant others” subscale scores.
Discussion: This study suggests that pain has a minimal impact on the
quality of life in Asian patients with depression. Noteworthy issues in this
population may include insomnia, obsessive–compulsive symptoms,
working/school disability, and family support.
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Introduction
Depressive disorders are a major public health
problem in most countries. In 2004, the World Health
Organization (WHO) estimated that approximately
151 million people across the world suffer from uni-
polar depressive disorder, of whom 80 million live in
South-East Asia and the Western Pacific region (WHO,
2008). Unipolar depressive disorder is a leading cause
of disability. It is the fourth leading cause of disability-
adjusted life years (DALYs) in South-East Asia, and the
second leading cause of DALYs in the Western Pacific
region.
Classification systems like the Diagnostic and Statis-
tical Manual of Mental Disorders (DSM) framework can
mask considerable cultural variation in the way that
depression is understood and expressed. Indeed, there
is a growing body of evidence that suggests differences
in depression between Asia and the West. First, a
lower prevalence of depression has long been
observed in the Asian population. Chiu (2004) com-
pared studies (albeit of varying methodology) in Asia
and the US, and noted that the lifetime prevalence
rates of DSM-III or DSM-IV depressive disorders
reported in Hong Kong (3.7%), South Korea (4.0%),
and Taiwan (1.1%) were considerably lower than that
reported in the US (17.1%) (Chiu, 2004). Two of the
17 countries that participated in the WHO’s World
Mental Health Survey Initiatives were from Asia
(namely, Japan and India), and by using a standard-
ized methodology across all participating countries,
the investigators showed that Japan has the lowest
1-year prevalence of depression (2.2%) among 10
developed countries (mean = 5.5%), and that India
has the second lowest prevalence (4.5%) among
seven developing countries across the globe
(mean = 5.9%) (Kessler et al., 2010).
Besides differences in prevalence, there also
appear to be differences in depressive symptomatology
between Asian and Western populations. For instance,
when comparing the results of the US National
Comorbidity Survey and the Korean Epidemiologic
Catchment Area Study, it was observed that Koreans
with major depressive disorder (MDD) were more
likely to express symptoms like “low energy” and
“concentration difficulty,” and less likely to express
symptoms like “depressed mood” and “thought of
death,” than their American counterparts (Lee et al.,
2007). In addition, according to the results of some
field research and anthropological studies, there
appears to be a greater tendency for Chinese people
with depression (as compared with their Western
counterparts) to complain of somatic symptoms
(Kleinman, 1977). Chinese people with depression
were also more likely to have some sociocultural pro-
tective factors against depression (Xu, 1987) and were
more likely to deny that they had depression (Parker
et al., 2001).
Over the past few years, a group of psychiatrists in
Australia and Asia have collaborated in a network
called the “Mood Disorder Research: Asian & Austra-
lian Network” or “MD RAN.” The ultimate goal of this
group is to gain greater knowledge regarding Asian
depression, in particular the similarities and differ-
ences of depression among Asian populations, and
between Asians and Caucasians. The Study on Aspects
of Asian Depression (SAAD) is the first study under-
taken by this network.
Aims of the study
The SAAD aimed to examine the clinical features of
depression in Asians and their beliefs/attitudes
toward depression. In this first paper of the SAAD, we
present data obtained from Asian sites. Those included
sociodemographic and clinical features, symptom pre-
sentation, health status, disability, and social support
profile.
Methods
Study design and settings
The SAAD was a multicountry, multicenter, cross-
sectional, observational study of depression in clinical
settings carried out between 2008 and 2010. Thirteen
SAAD study sites were established across six Asian
countries: China, Korea, Malaysia, Singapore, Taiwan,
and Thailand. One study site was established in
Australia to recruit a Caucasian comparison group.
Outside of Australia, the study sites within Asia were
as follows: Beijing Anding Hospital (Beijing, China),
Institute of Mental Health (Beijing, China), Shanghai
Mental Health Center (Shanghai, China), Kyungpook
National University Hospital (Daegu, Korea), Inha
University Hospital (Incheon, Korea), Asan Medical
Center (Seoul, Korea), Samsung Medical Center Uni-
versity School of Medicine (Seoul, Korea), University
of Malaya Medical Center (Kuala Lumpur, Malaysia),
Institute of Mental Health Woodbridge Hospital (Sin-
gapore), Chung Gang Memorial Hospital (Taoyuan
County, Taiwan), McKay Memorial Hospital (Taipei
City, Taiwan), Maharaj Nakorn Chiang Mai Hospital
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(Chiang Mai, Thailand), and Prince of Songkla Uni-
versity (Songkhla, Thailand). All 14 study sites
provide psychiatric care for the public or private
sector. The study did not involve any clinical manage-
ment of the enrolled participants, and it was approved
by the institutional review board or ethics committee
of each site.
Participants
Participants were prospectively enrolled from outpa-
tients seeking psychiatric treatment at the respective
study sites. Individuals who presented for an intake
appointment were approached by a study coordinator
to participate in the study. After the study details had
been fully explained, written informed consent was
obtained from each participant. The inclusion criteria
were as follows:
• male or female aged 18–65 years
• a positive response (“yes”) to the Mini-International
Neuropsychiatric Interview (M.I.N.I.) question A1
(depressed mood) and/or A2 (loss of interest)
(Sheehan et al., 1998)
The exclusion criteria included the following:
• unstable medical condition
• mood disorder due to medical conditions and/or
substance abuse
• psychotic or bipolar disorder
• clinically significant cognitive impairment
• treatment with psychotropic medication within the
previous month
• treatment with a benzodiazepine within the previ-
ous week
• treatment with long-acting antipsychotic medica-
tion within the previous 3 months
All other psychiatric and comorbid conditions
were permitted.
Variables
Sociodemographic characteristics were recorded at
baseline, including age, gender, ethnicity, education,
marital status, work status, living situation, and reli-
gion. Clinical indicators were also recorded at baseline,
including age at first onset, duration of index episode,
length of illness, number of past psychiatric hospital-
izations, type of psychiatric disorder (as defined by the
M.I.N.I.), and depressive severity.
Assessment
Participants completed several self-report measures in
the presence of the study coordinator. A face-to-face
interview was then conducted with the site investiga-
tor before participants met with their treating clini-
cian. The order of data collection was intended to keep
the participant’s perceptions of depression (or what-
ever was their perceived illness) free from being influ-
enced by the interview or the response to rating scales
applied in this study. Data collection was accomplished
in a single visit.
Symptom measures included the Montgomery–
Asberg Depression Rating Scale (MADRS)
(Montgomery and Asberg, 1979), the Symptoms
Checklist 90-Revised (SCL-90-R) (Derogatis, 1977),
and the Fatigue Severity Scale (FSS) (Krupp et al.,
1989). Health status was assessed using the Medical
Outcome Survey 36-Item Short-Form Health Survey
(SF-36) (Ware and Sherbourne, 1992). Functional
impairment was evaluated using the Sheehan Disabil-
ity Scale (SDS) (Sheehan et al., 1996). Social support
was assessed using the Multidimensional Scale of Per-
ceived Social Support (MSPSS) (Zimet et al., 1990).
Two additional scales were used but will be reported in
a subsequent paper. These are the List of Threatening
Experiences Questionnaire (LTE-Q) (Brugha et al.,
1985) and a modified version of the Explanatory
Model Interview Catalogue (m-EMIC) (Weiss et al.,
1992).
Except for the M.I.N.I. and MADRS, all question-
naires were self-administered. Lundbeck Export A/S
supervised the acquisition of versions in Chinese (both
traditional and simplified), Korean, Malay, and Thai.
The licenses to use the English or validated transla-
tions of the SCL-90-R, SDS, SF-36, M.I.N.I., and
MADRS were secured from the respective scale pro-
prietors. A protocol for forward and backward trans-
lation was implemented to produce the equivalent
translations of the FSS, MSPSS, LTE-Q, and m-EMIC.
The latter set of scales was not pilot-tested.
All scales presented within this paper are briefly
described below.
MADRS
The MADRS is a depression rating scale that comprises
10 items that assess the core symptoms of depression:
apparent sadness, reported sadness, inner tension,
reduced sleep, reduced appetite, concentration diffi-
culties, lassitude, inability to feel, pessimistic thoughts,
and suicidal thoughts. Each item is scored from 0 to 6,
with 0 denoting the absence of the symptom and 6
denoting the most severe form of the symptom. The
participants were classified as having mild (0–18
points), moderate (19–29 points), or severe depression
(30–60 points) (Snaith et al., 1986; Bech et al., 2006).
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SCL-90-R
The SCL-90-R is a 90-item inventory to assess psycho-
logical symptom status on nine dimensions (or
subscales): somatization, obsession–compulsion, inter-
personal sensitivity, depression, anxiety, hostility,
phobic anxiety, paranoid ideation, and psychoticism.
Each subscale is rated from 0 (indicating no distress) to
4 (indicating extreme distress).
FSS
The FSS is a nine-item questionnaire to assess the
severity of fatigue related to physical functioning,
exercise, work, family, and social life. Each item is
scored from 1 (indicating no fatigue) to 7 (indicating
extreme fatigue) and is averaged to give the mean
score.
SDS
The SDS is a three-item scale designed to assess per-
ceived disability in three areas of the patient’s life:
work/school, social life/leisure, and family/home life.
Each item is rated from 1 (indicating no disability) to
10 (indicating extreme disability), and all items are
summed to provide a total score ranging from 3 to 30.
SF-36
The SF-36 is a 36-item questionnaire that measures
self-perceived general health across eight health status
domains (or subscales): physical functioning, role
limitations due to physical health, bodily pain, general
health perceptions, vitality, social functioning, role
limitations due to emotional problems, and mental
health. Each subscale is scored from 0 to 100, with
higher scores indicating a better health state.
MSPSS
The MSPSS is a 12-item scale that measures perceived
social support from three sources (or subscales):
family, friends, and significant other. Each subscale is
scored from 1 to 7. The subscale scores are averaged to
give the mean total score, with higher scores indicat-
ing greater perceived social support.
Statistical analysis
Data were summarized as mean (SD) and percentage
of the entire cohort. An examination showed that the
great majority of the participants completed the scales
with no missing data. For any given outcome, the




A total of 1,917 outpatients were screened for eligibil-
ity, of whom 637 (33.2%) were eligible. The reasons
for screen failure were as follows: use of psychotropic
medication (370 patients, 28.9%); failure to meet the
M.I.N.I. criteria (308 patients, 24.1%); presence of
psychotic or bipolar disorder (226 patients, 17.7%);
age above 65 years (127 patients, 9.9%); presence of
mood disorders due to medical conditions or sub-
stance abuse (97 patients, 7.6%); age below 18 years
(69 patients, 5.4%); refusal to provide informed
consent (56 patients, 4.4%); or presence of an
unstable or comorbid medical condition (27 patients,
2.1%).
Of 637 patients confirmed eligible, 556 were
enrolled. The remaining patients were not enrolled
for one of the following reasons: refusal/
unwillingness to cooperate (58 patients), lack of
patience to be interviewed (14 patients), or lack of the
time to participate in the study (9 patients). All par-
ticipants were compensated for their time. The mean
(SD) time taken for completion of self-administered
scales was 35.8 (14.1) minutes, and for face-to-face
interview it was 38.1 (13.8) minutes. Nine enrolled
patients were further excluded because they had no
current major depressive episode (MDE), as con-
firmed by the M.I.N.I. After the exclusion, all 547
participants included in the analysis met the DSM-IV
diagnosis of MDD.
Sociodemographic features
The countries of origin were as follows: 114 partici-
pants were from China (20.8%), 101 from Korea
(18.5%), 130 from Malaysia/Singapore (24.0%) (90
from Malaysia and 40 from Singapore), 103 from
Thailand (18.6%), and 99 from Taiwan (18.1%). In
terms of gender, 352 (64.4%) participants were female
(Table 1). The mean (SD) age was 39.6 (13.2) years.
With respect to depression severity, 10.2% of partici-
pants had mild depression (n = 56), 40.2% had mod-
erate depression (n = 220), and 49.5% had severe
depression (n = 271). Most participants were married/
cohabiting, employed, or living with families. Most
had no religion or were Buddhists.
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Clinical features
The mean (SD) age at first onset was 36.4 (13.3)
years (Table 2). The mean (SD) duration of index
episode was 79.3 (162.9) weeks, and the mean (SD)
length of illness was 3.2 (5.4) years. Approximately
28.7% of the participants (n = 157) reported no pre-
vious psychiatric hospitalization. The highest per-
centage of participants (62.9%) had MDE only
(n = 344), and only 4.8% of participants (n = 26)
had MDE with atypical features (with or without
melancholic features).
Symptom presentation
Among the MADRS symptom scores, “reported
sadness” and “reduced sleep” had the highest mean
(SD) scores of 3.4 (1.2) and 3.4 (1.6), and “suicidal
thoughts” had the lowest mean (SD) score of 2.0 (1.6)
(Table 3). The mean (SD) obsession–compulsion
subscale score of 1.9 (0.9) was almost as high as the
depression subscale (SD) score of 2.0 (0.9). The mean
(SD) FSS score was 5.0 (1.4).
Health status, disability, and social support
Of the eight SF-36 domains, the “vitality” had the
lowest mean (SD) score of 25.7 (19.1), and “physical
functioning” had the highest mean (SD) score of 77.6
(23.5), followed by the pain mean (SD) score of 58.4
(27.8) (Table 4). Among the three areas of the
patient’s life, “work/school” had the highest mean
(SD) score of 6.5 (2.9). The mean (SD) MSPSS






Age (years) 39.6 (13.2)
n (%)
Gender (female) 352 (64.4%)
Ethnicity
Chinese CN 114 (20.8%)
Chinese TW 99 (18.1%)
Chinese MY/SG† 77 (14.1%)
Korean 101 (18.5%)
Thai 102 (18.6%)
Other Asians (e.g. Malay, Indian) 54 (9.9%)
Education (% completed secondary education) 413 (75.5%)
Marital status






















†MY/SG (n’s) = 43/34.
CN, China; MY/SG, Malaysia/Singapore; TW, Taiwan.
Table 2. Clinical features, disability, and support features of Asian
patients with major depressive disorders
Features Total (n = 547)
Mean (SD)
MADRS score 29.1 (8.1)
Age at first onset 36.4 (13.3)
Index episode duration (weeks) 79.3 (162.9)
Length of illness (years) 3.2 (5.4)
n (%)





MDE only 344 (62.9%)
MDE with melancholia 174 (31.8%)
MDE with atypical features 26 (4.8%)





Social life/leisure 5.8 (3.0)





Significant others 4.6 (1.8)
MADRS, Montgomery–Asberg Depression Rating Scale; MDE, major
depressive episode; M.I.N.I., Mini-International Neuropsychiatric
Interview; MSPSS, Multidimensional Scale of Perceived Social Support;
SDS, Sheehan Disability Scale.
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“family” subscale score of 4.7 (1.7) was higher than
the MSPSS “friends” and “significant others” subscale
scores.
Discussion
The participants of this study were a mix of Asian
ethnic groups. Of the 547 participants, approximately
half were Chinese (53%). As measured by the
MADRS, reduced sleep was as severe as was reported
sadness. The SCL-90-R scores suggest that obsessive–
compulsive syndrome is prominent among Asian
patients with depression. As the higher SF-36 scores
indicates a better health state, given that “pain”
ranked the second highest among SF-36 subscale
scores, this may indicate that pain has minimal impact
on the quality of life in these patients. The SDS scores
reflected that Asian patients with depression find their
symptoms to be most disruptive to their work/school
rather than to their family lives or their social lives.
However, family was their leading source of social
support.
This study’s finding that reduced sleep or insom-
nia is as severe as reported sadness is in line with
previous studies. Several studies in the West and a
study in Taiwan have found that more than 90% of
depressed patients have poor sleep (Thase, 1999; Hsu
et al., 2009).
Obsessive–compulsive symptoms have long been
observed in Western patients with depression. Indeed,
it is noteworthy that in one of the most widely used
rating scales for assessing depression (the Hamilton
Rating Scale for Depression), these symptoms have
been singled out as a separate entity (Hamilton, 1960).
In examining the medical records of 398 inpatients
with depression in the UK, Gittleson (1966) found
obsessive symptoms among 124 patients (31.2%)
(Gittleson, 1966). In a US study, obsessive–compulsive
symptoms were found in 36% of MDD patients
(Wisner et al., 1999). Although the present study
did not examine the prevalence of obsessive–
compulsive symptoms per se, the finding of high SCL-
90-R scores on the obsessive–compulsion subscale
appears to mirror the findings in the West. On a sepa-
rate note, the findings of this study do not support
previous findings of prominent somatization in Asians
with depression (Kleinman, 1977). The present
somatization subscale scores were around average as
compared with the other eight subscale scores of the
SCL-90-R.
Studies in the West suggest that depression and
painful symptoms commonly occur together (Bair
Table 3. MADRS symptom and SCL-90-R syndrome profiles in Asian
patients with major depressive disorders
Mean (SD)
MADRS symptom
1. Apparent sadness 3.2 (1.1)
2. Reported sadness 3.4 (1.2)
3. Inner tension 3.2 (1.2)
4. Reduced sleep 3.4 (1.6)
5. Reduced appetite 2.3 (1.7)
6. Concentration difficulties 3.2 (1.3)
7. Lassitude 2.7 (1.5)
8. Inability to feel 3.2 (1.3)
9. Pessimistic thoughts 2.7 (1.4)
10. Suicidal thoughts 2.0 (1.6)
SCL-90-R syndrome
1. Somatization 1.3 (0.8)
2. Obsession–compulsion 1.9 (0.9)
3. Interpersonal sensitivity 1.4 (0.9)
4. Depression 2.0 (0.9)
5. Anxiety 2.0 (0.9)
6. Hostility 1.2 (0.9)
7. Phobic anxiety 1.0 (0.9)
8. Paranoid ideation 1.2 (0.9)
9. Psychoticism 1.1 (0.8)
MADRS, Montgomery–Asberg Depression Rating Scale; SCL-90-R,
Symptoms Checklist 90-Revised.
Table 4. Health status (SF-36), disability (SDS), and social support
(MSPSS) profiles in Asian patients with major depressive disorders
Mean (SD)
SF-36
1. Physical functioning 77.6 (23.5)
2. Role limitations due to
physical health
48.9 (28.8)
3. Bodily pain 58.4 (27.8)
4. General health perceptions 36.1 (21.1)
5. Vitality 25.7 (19.1)
6. Social functioning 45.2 (25.2)
7. Role limitations due to
emotional problems
38.9 (26.8)
8. Mental health 31.4 (18.7)
SDS
1. Work/school 6.5 (2.9)
2. Social life/leisure 5.8 (3.0)
3. Family/home life 5.5 (3.2)
4. Total 17.1 (8.0)
MSPSS
1. Social support from family 4.7 (1.7)
2. Social support from friends 4.2 (1.6)
3. Social support from
significant others
4.6 (1.8)
4. Total social support 4.4 (1.4)
MSPSS, Multidimensional Scale of Perceived Social Support; SDS,
Sheehan Disability Scale; SF-36, Medical Outcome Survey 36-Item
Short-Form Health Survey.
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et al., 2003). Recent studies in Asia also support this
observation. For example, Lee and Tsang (2009)
showed that in Hong Kong, painful physical symp-
toms were strongly associated with depression (Lee
and Tsang, 2009), while Lee et al. (2009) showed that
painful physical symptoms were experienced by
approximately half of Taiwanese patients with MDD
(Lee et al., 2009). In a survey of a multiethnic US
sample of 480 cancer patients, the Asian Americans
reported the lowest pain scores on multiple types of
scales as compared with Hispanic, non-Hispanic
White, and African American (Im et al., 2007). Such
low pain scores appeared to be in concordance with
the present finding that pain had less impact on Asian
depressed patients’ health. Taken together, it may be
speculated that pain is a common symptom among
Asian patients with depression, but has minimal
impact on their quality of life. More studies of pain in
multiethnic samples with depression may help clarify
this complex symptom.
While it is widely accepted that depression can
cause severe functional impairment, there is a dearth
of research that assesses multiple dimensions of psy-
chosocial functioning in a population with depression.
Nonetheless, there was a small US study (which just as
in this present study used the SDS for measuring dis-
ability) that suggests that social life is the most
impacted domain, followed by family, and then work/
school lives (Kennedy et al., 2002). The present study,
on the other hand, found work/school life to be the
most impacted, followed by social, and then family
lives. The discrepancy between the present study and
the US study may reflect cultural differences between
Asia and the West regarding functional priorities.
There are several limitations of the present study.
First, imbalances in ethnic representation across
groups may have had significant influence on the
study results. A study involving three countries in Asia
showed differences in symptom presentation between
countries (Nakane et al., 1991), which in turn serves
as a caution to the assumption that depression is
uniform across Asia.
Second, caution should be applied in generalizing
the study findings. The exclusion of patients treated
with psychotropic medications allowed us to have a
clear picture of the psychiatric symptoms in our par-
ticipants, but may inadvertently have led to the exclu-
sion of many patients commonly seen in typical clinic
settings. This study also did not employ random sam-
pling procedures. Moreover, this study primarily
enrolled patients from tertiary care settings. Third,
this study could not recruit as wide a range
of patients with depression as originally planned.
Because the Western concept of depression may not
cover the full spectrum of depressive symptoms
observed among Asian populations (Lee et al., 2007),
we intended to enroll a wide range of depressed
patients through the use of loose inclusion criteria.
This was to enable the participation of patients with
core symptoms of depression (depressed mood and
loss of interest) who might not have met the DSM-IV
diagnostic criteria for current MDE. In primary care
settings, the specificity of this two-question screening
test for depression is approximately 67% (Arroll et al.,
2003), implying that about a third of patients having a
positive response to this test do not meet the DSM-IV
criteria for MDD. However, when we applied this
same strategy in our tertiary care settings, only 9 of
556 participants did not meet the criteria for a current
MDE diagnosis. Due to the small numbers involved,
we had less reservation about excluding them from
the present analyses. Fourth, despite the rigorous
methodology set in place for scales translation,
nuances may have been lost in translation, especially
the MPSSS, which was only translated and back-
translated. In addition, this study had no rating scale
training as a group and no inter-rater reliability study.
Finally, although comorbidity is very common in
patients with depression, the present study did not
assess comorbidity. Therefore, it remains unknown
whether comorbidity (e.g. substance use disorders)
had any impact on the study results.
Despite the above-mentioned limitations, this
study’s findings provide insight for understanding the
clinical features of Asian depression. In addition to
depressive symptoms, insomnia, obsession, compul-
sion, and pain may be clinically significant in this
population. Still, pain does not seem to have a signifi-
cant impact on a patient’s quality of life. Depression-
related symptoms appear to be most disruptive to
work/school life for the Asian patient with depression,
as compared with family life or social life. Given that
patients perceived family to be a leading source of
social support, family members may have an impor-
tant role in helping this population. Further studies in
these areas are warranted.
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